References

1 Longstreth G. F. et al. Functional Bowel Disorders. Gastroenterol 2006;130:1480-1491

2 Brandt L. J. et al. An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome. AJG 2009;104, Suppl 1;S1-S35

3 Hungin A. P. S. et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003;17:643-650

4 Drossman D. A. et al. The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach. Annals of Internal Medicine 1992;116, Number 12 (Part 1):1009-1016

5 Hershfield NB. Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey. Can J Gastroenterol. 2005;19(4):231

6 Drossman D. A. et al. The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach. Annals of Internal Medicine 1992;116, Number 12 (Part 1):1009-1016

7 Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A, San Felice del Benaco. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol. 2012;107(6):891

8 Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009 Jan;104 Suppl 1:S1-35

9 Schmulson MW, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med. 1999;107(5A):20S

10 Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997 Dec;32(6):765-8

11 Vanuytsel T, Tack JF, Boeckxstaens GE.Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014 Aug; 49(8):1193-205

12 Spencer M, Chey WD, Eswaran S. Dietary renaissance in IBS: has food replaced medications as a primary treatment strategy? Curr Treat Options Gastroenterol. 2014 Dec;12(4):424-40

13 Bennet SMP, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut liver. 2015 May;9(3):318-31

14 Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997 Dec;32(6):765-8

15 Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci. 2010 May;55(5):1385-90

16 Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014 Jul;48(6):505-12.
Legal disclaimer | Privacy policy | © 2013 by Tillotts Pharma AG